TorsinA and DYT1 early-onset dystonia

Future Neurology

Volumn 3, Issue 1, 2008, Pages 61-72

  Kamm, Christoph ^a   Ozelius, Laurie J ^b   Breakefield, Xandra O ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Human genetics; Inherited neurologic disease; Movement disorder

Indexed keywords

CELL PROTEIN; CHAPERONE; GAG PROTEIN; LEVODOPA; PROTEIN AAA; PROTEIN DYT1; PROTEIN TORSINA; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; CELL NUCLEUS MEMBRANE; CLINICAL FEATURE; CYTOSKELETON; EARLY ONSET DYSTONIA; ENDOPLASMIC RETICULUM; EXON; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC VARIABILITY; HUMAN; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TORSION DYSTONIA;

EID: 37649008757     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.3.1.61     Document Type: Review

References (123)

1. Geyer HL, Bressman SB: The diagnosis of dystonia. Lancet Neurol. 5, 780-790 (2006).
2. Tarsy D, Simon DK: Dystonia. N. Engl. J. Med. 355, 818-829 (2006).
3. Klein C, Ozelius LJ, Breakefield XO: Genetic evaluation in primary dystonia. In: Handbook of Dystonia. Stacy M (Ed.). Taylor and Francis Group, NY, USA 21-44 (2007).
4. Ozelius LJ, Hewett JW, Page CE et al.: The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17, 40-48 (1997).
5. Gimenez-Roldan S, Delgado G, Marin M, Villanueva JA, Mateo D: Hereditary torsion dystonia in gypsies. Adv. Aeurol. 50, 73-81 (1988).
6. Khan NL, Wood NW, Bhatia KP: Aurosomal recessive, DYT2-like primary torsion dystonia: a new family. Neurology 61, 1801-1803 (2003).
7. Parker N: Hereditary whispering dysphonia. J. Neurol. Neurosurg. Pychiatry 48, 218-224 (1985).
8. Ahmad F, Davis MB, Waddy HM, Cley CA, Marsden CD, Harding AE: Evidence for locus heterogeneity in autosomal dominant torsion dystonia. Genomics 15, 9-12 (1993).
9. Almasy L, Bressman SB, Raymond D et al.: Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann. Neurol. 42, 670-673 (1997).
10. Leube B, Rudnicki D, Ratzlaff T, Kessler KR, Benecke R, Auburger G: Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum. Mol. Genet. 5, 1673-1677 (1996).
11. Valente EM, Bentivoglio AR, Cassetta E et al.: DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Ann. Neurol. 49, 362-366 (2001).
12. Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H: Hereditary progressive dystonia with marked diurnal fluctuation. Adv. Neurol. 14, 215-233 (1976).
13. Asmus F, Salih F, Hjermind LE et al.: Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann. Neurol. 58, 792-797 (2005).
14. +-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43, 169-175 (2004).
15. Rainier S, Thomas D, Tokarz D et al.: Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch. Neurol. 61, 1025-1029 (2004).
16. Lee HY, Xu Y, Huang Y et al.: The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum. Mol. Genet. 13, 3161-3170 (2004).
17. Greene P, Kang UJ, Fahn S: Spread of symptoms in idiopathic torsion dystonia. Mov. Disord. 10, 143-152 (1995).
18. Bressman SB, Sabatti C, Raymond D et al.: The DYT1 phenotype and guidelines for diagnostic testing. Neurology 54, 1746-1752 (2000).
19. ESDE Collaborative Group: Sex-related influences on the frequency and age of onset of primary dystonia. Neurology 53, 1871-1873 (1999).
20. Defazio G, Berardelli A, Abbruzzese G et al.: Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group. J. Neurol. Neurosurg. Psychiatry 67, 613-619 (1999).
21. Jahanshahi M, Marion MH, Marsden CD: Natural history of adult-onset idiopathic torticollis. Arch. Neurol. 47, 548-552 (1990).
22. Nutt JG, Muenter MD, Melton L Jr, Aronson A, Kurland LT: Epidemiology of dystonia in Rochester, Minnesota. Adv. Aeurol. 50, 361-365 (1988).
23. Muller J, Kiechl S, Wenning GK et al.: The prevalence of primary dystonia in the general community. Neurology 59, 941-943 (2002).
24. Risch NJ, Bressman SB, de Leon D et al.: Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am. J. Hum. Genet. 46, 533-538 (1990).
25. Klein C, Brin MF, de Leon D et al.: De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia. Hum. Mol. Genet. 7, 1133-1136 (1998).
26. Ghilardi MF, Carbon M, Silvestri G et al.: Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann. Neurol. 54, 102-109 (2003).
27. Carbon M, Kingsley PB, Su S et al.: Microstructural white marter changes in carriers of the DYT1 gene mutation. Ann. Neurol. 56, 283-286 (2004).
28. Asanuma K, Ma Y, Okulski J et al.: Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64, 347-349 (2005).
29. Eidelberg D, Moeller JR, Antonini A et al.: Functional brain networks in DYT1 dystonia. Ann. Neurol. 44, 303-312 (1998).
30. Hedreen JC, Zweig RM, DeLong MR, Whitehouse PJ, Price DL: Primary dystonias: a review of the pathology and suggestions for new directions of study. Adv. Neurol. 50, 123-132 (1988).
31. Rostasy K, Augood SJ, Hewett JW et al.: TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 12, 11-24 (2003).
32. McNaught KS, Kapustin A, Jackson T et al.: Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 56, 540-547 (2004).
33. Defazio G, Berardelli A, Hallett M: Do primary adult-onset focal dystonias share aetiological factors? Brain 130, 1183-1193 (2007).
34. Heiman GA, Ottman R, Saunders-Pullman RJ, Ozelius LJ, Risch NJ, Bressman SB: Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology 63, 631-637 (2004).
35. Gasser T, Windgassen K, Bereznai B, Kabus C, Ludolph AC: Phenotypic expression of the DYT1 mutation: a family with writer's cramp of juvenile onset. Ann. Neurol. 44, 126-128 (1998).
36. Opal P, Tintner R, Jankovic J et al.: Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov. Disord. 17, 339-345 (2002).
37. Ikeuchi T, Shimohata T, Nakano R, Koide R, Takano H, Tsuji S: A case of primary torsion dystonia in Japan with the 3-bp (GAG) deletion in the DYT1 gene with a unique clinical presentation. Neurogenetics 2, 189-190 (1999).
38. Leube B, Kessler KR, Ferbert A et al.: Phenotypic variability of the DYT1 mutation in German dystonia patients. Acta Neurol. Scand. 99, 248-251 (1999).
39. Edwards M, Wood N, Bhatia K: Unusual phenotypes in DYT1 dystonia: a report of five cases and a review of the literature. Mov. Disorder. 18, 706-711 (2003).
40. Van Den Bos M, Marotta R, Goldup S et al.: Writer's cramp in an Australian pedigree with DYT1 dystonia. J. Clin. Neurosci. 11, 537-539 (2004).
41. Gambarin M, Valente EM, Liberini P et al.: Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia. Mov. Disord. 21, 1782-1784 (2006).
42. Ozelius LJ, Page CE, Klein C et al.: The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics 62, 377-384 (1999).
43. Dron M, Meritet JF, Dandoy-Dron F, Meyniel JP, Maury C, Tovey MG: Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins. Genomics 79, 315-325 (2002).
44. Basham SE, Rose LS: The Caenorhabditis elegans polarity gene ooc-5 encodes a Torsin-related protein of the AAA ATPase superfamily. Development 128, 4645-4656 (2001).
45. Caldwell GA, Cao S, Sexton EG, Gelwix CC, Bevel JP, Caldwell KA: Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum. Mol. Genet. 12, 307-319 (2003).
46. Cao S, Gelwix CC, Caldwell KA, Caldwell GA: Torsin-modiated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25, 3801-3812 (2005).
47. Koh YH, Rehfeld K, Ganetzky B: A Drosophila model of early onset torsion dystonia suggests impairment in TGF-β signaling. Hum. Mol. Genet. 13, 2019-2030 (2004).
48. Muraro NI, Moffat KG: Down-regulation of torp4a, encoding the Drosophila homologue of torsinA, results in increased neuronal degeneration. J. Neurobiol. 66, 1338-1353 (2006).
49. Lupas A, Flanagan JM, Tamura T, Baumeister W: Self-compartmentalizing proteases. Trends Biochem. Sci. 22, 399-404 (1997).
50. +: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genomic Res. 9, 27-43 (1999).
51. Kock N, Naismith TV, Boston HE et al.: Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier. Hum. Mol. Genet. 15, 1355-1364 (2006).
52. + proteins: have engine, will work. Nat. Rev. Mol. Cell Biol. 6, 519-529 (2005).
53. Vale RD: AAA proteins. Lords of the ring. J. Cell Biol. 150, F13-F19 (2000).
54. Hewett J, Gonzalez-Agosti C, Slater D et al.: Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum. Mol. Genet. 9, 1403-1413 (2000).
55. Kustedjo K, Bracey MH, Cravatt BF: TorsinA and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J. Biol. Chem. 275, 680-685 (2000).
56. Torres GE, Sweeney AL, Beaulieu JM, Shashidharan P, Caron MG: Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant: Proc. Natl Acad. Sci. USA 101, 15650-15655 (2004).
57. Hewett JW, Tannous B, Niland BP et al.: Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc. Natl Acad. Sci USA 104, 7271-7276 (2007).
58. Boyce M, Yuan J: Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 13, 363-373 (2006).
59. Zhang K, Kaufman RJ: The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66, S102-S109 (2006).
60. McLean PJ, Kawamata H, Shariff S et al.: TorsinA and heat shock proteins act as molecular chaperones: suppression of α-synuclein aggregation. J. Neurochem. 83, 846-854 (2002).
61. Kuner R, Teismann P, Trutzel A et al.: TorsinA protects against oxidative stress in COS-1 and PC12 cells. Neurosci. Lett. 350, 153-156 (2003).
62. Hewett J, Ziefer P, Bergeron D et al.: TorsinA in PC12 cells: localization in the endoplasmic reticulum and response to stress. J. Neurosci. Res. 72, 158-168 (2003).
63. Shashidharan P, Paris N, Sandu D et al.: Overexpression of torsinA in PC12 cells protects against toxicity. J. Neurochem. 88, 1019-1025 (2004).
64. Naismith TV, Heuser JE, Breakefield XO, Hanson PI: TorsinA in the nuclear envelope. Proc. Natl Acad. Sci. USA 101, 7612-7617 (2004).
65. Goodchild RE, Dauer WT: Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc. Natl Acad. Sci. USA 101, 847-852 (2004).
66. Gonzalez-Agosti P, Paulson HL: Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J. Neurosci. 24, 2593-2601 (2004).
67. Kamm C, Boston H, Hewett J et al.: The early onset dystonia protein torsinA interacts with kinesin light chain 1. J. Biol. Chem. 279, 19882-19892 (2004).
68. Goodchild RE, Kim CE, Dauer WT: Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48, 923-932 (2005).
69. Berardelli A, Rothwell JC, Hallett M, Thompson PD, Manfredi M, Marsden CD: The pathophysiology of primary dystonia. Brain 121, 1195-1212 (1998).
70. Xiao J, Gong S, Zhao Y, LeDoux MS: Developmental expression of rat torsinA transcript and protein. Brain Res. Dev. Brain Res. 152, 47-60 (2004).
71. Vasudevan A, Breakefield XO, Bhide P: Developmental patterns of torsinA and torsinB expression. Brain Res. 1073-1074, 139-145 (2006).
72. Dang MT, Yokoi F, McNaught KS et al.: Generation and characterization of Dyt1 ΔGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452-463 (2005).
73. Augood SJ, Keller-McGandy CE, Siriani A et al.: Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Res. 986, 12-21 (2003).
74. Shashidharan P, Kramer BC, Walker RH, Olanow CW, Brin MF: Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res. 853, 197-206 (2000).
75. Oberlin SR, Konakova M, Pulst S, Chesselet MR: Development and anatomic localization of torsinA. Adv. Neurol. 94, 61-65 (2004).
76. Breakefield XO, Kamm C, Hanson PI: TorsinA: movement at many levels. Neuron 31, 9-12 (2001).
77. Dang MT, Yokoi F, Pence MA, Li Y: Motor deficits and hyperactivity in DYT1 knockdown mice. Neurosci. Res. 56, 470-474 (2006).
78. Leung JC, Klein C, Friedman J et al.: Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 3, 133-143 (2001).
79. Kabakci K, Hedrich K, Leung JC et al.: Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology 62, 395-400 (2004).
80. Walker RH, Brin MF, Sandu D, Good PF, Shashidharan P: TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology 58, 120-124 (2002).
81. Hewett JW, Zeng J, Niland BP, Bragg DC, Breakefield XO: Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol. Dis. 22, 98-111 (2006).
82. Misbahuddin A, Placzek MR, Taanman JW et al.: Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Disord. 20, 432-440 (2005).
83. Shashidharan P, Sandu D, Potla U et al.: Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 14, 125-133 (2005).
84. Grundmann K, Reischmann B, Vanhoutte G et al.: Overexpression of human wildtype torsiaA and human ΔGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 27, 190-206 (2007).
85. Sharma N, Baxter MG, Petravicz J et al.: Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 5351-5355 (2005).
86. Pisani A, Martella G, Tscherter A et al.: Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 24, 318-325 (2006).
87. Balcioglu A, Kim M-O, Sharma N, Cha J-H, Breakefield XO, Standaert DG: Dopamine release is impaired in a mouse model of DYT1 dystonia. J. Neurochem. 102, 783-788 (2007).
88. Risch N, Bressman S, Senthil G, Ozelius L: Intragenic cis and trans modification of genetic susceptibility in DYT1 torsion dystonia. Am. J. Hum. Genet. 80, 1188-1193 (2007).
89. Doherty D, Danisi F, Smith C et al.: Clinical findings of a myodonus-dystonia family with two distinct mutations. Neurology 59, 1244-1246 (2002).
90. Zimprich A, Grabowski M, Asmus F et al.: Mutations in the gene encoding ε-sarcoglycan cause myoclonus-dystonia syndrome. Nat. Genet. 29, 66-69 (2001).
91. Singleton A, Myers A, Hardy J: The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. Hum. Mol. Genet. 13, R123-R126 (2004).
92. Olson JM, Goddard KA, Dudek DM: The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am. J. Hum. Genet. 69, 895-899 (2001).
93. Mueller JC, Fuchs J, Hofer A et al.: Multiple regions of α-synuclein are associated with Parkinson's disease. Ann. Neurol. 57, 535-541 (2005).
94. Mead S, Mahal SP, Beck J et al.: Sporadic - but not variant - Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am. J. Hum. Genet. 69, 1225-1235 (2001).
95. Clarimon J, Asgeirsson H, Singleton A et al.: Torsin A haplotype predisposes to idiopathic dystonia. Ann. Neurol. 57, 765-767 (2005).
96. Kamm C, Asmus F, Muller J et al.: Strong genetic evidence for association of TOR1A/TOR1B with idiopathic dystonia. Neurology 67, 1857-1859 (2006).
97. Hague S, Klaffke S, Clarimon J et al.: Lack of association with torsinA haplotype in German patients with sporadic dystonia. Neurology 66, 951-952 (2006).
98. Clarimon J, Brancati F, Peckham E et al.: Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasm. Mov. Disord. 22, 162-166 (2007).
99. Sibbing D, Asmus F, Konig IR et al.: Candidate gene studies in focal dystonia. Neurology 61, 1097-1101 (2003).
100. Valente EM, Warner TT, Jarman PR et al.: The role of DYT1 in primary torsion dystonia in Europe. Brain 121, 2335-2339 (1998).
101. Lebre AS, Durr A, Jedynak P et al.: DYT1 mutation in French families with idiopathic torsion dystonia. Brain 122, 41-45 (1999).
102. Slominsky PA, Markova ED, Shadrina MI et al.: A common 3-bp deletion in the DYT1 gene in Russian Families with early-onset torsion dystonia. Hum. Mutat. 14,269 (1999).
103. Nomura Y, Ikeuchi T, Tsuji S, Segawa M: Two phenotypes and anticipation observed in Japanese cases with early onset torsion dystonia (DYT1) - pathophysiological consideration. Brain Dev. 22, S92-S101 (2000).
104. Matsumoto S, Nishimura M, Kaji R et al.: DYT1 mutation in Japanese patients with primary torsion dystonia. Neuroreport 12, 793-795 (2001).
105. Szczaluba K, Jurek M, Milewski M et al.: Clinical characteristics of carriers of a GAG deletion in the DYT1 gene amongst Polish patients with primary dystonia. Eur. J. Neurol. 14, 659-662 (2007).
106. Lin YW, Chang HC, Chou YH et al.: DYT1 mutation in a cohort of Taiwanese primary dystonias. Parkinsonism Relat. Disord. 12, 15-19 (2005).
107. Risch N, de Leon D, Ozelius L et al.: Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat. Genet. 9, 152-159 (1995).
108. Valente EM, Povey S, Warner TT, Wood NW, Davis MB: Detailed haplotype analysis in Ashkenazi Jewish and non-Jewish British dystonic patients carrying the GAG deletion in the DYT1 gene: evidence for a limited number of founder mutations. Ann. Hum. Genet. 63(Pt 1), 1-8 (1999).
109. Carmona J, Burguera JA, Molla B et al.: Unique origin and low penetrance of the 946delGAG mutation in Valencian DYT1 families. Clin. Genet. 64, 153-159 (2003).
110. Elia AE, Filippini G, Bentivoglio AR, Fasano A, Ialongo T, Albanese A: Onset and progression of primary torsion dystonia in sporadic and familial cases. Eur. J. Neurol. 13, 1083-1088 (2006).
111. Hjermind LE, Wardelin LM, Sorensen SA: Inherited and de novo mutations in sporadic cases of DYT1-dystonia. Eur. J. Hum. Genet. 10, 213-216 (2002).
112. Zorzi G, Garavaglia B, Invernizzi F et al.: Frequency of DYT1 mutation in early onset primary dystonia in Italian patients. Mov. Disord. 17, 407-408 (2002).
113. Brassat D, Camuzat A, Vidailhet M et al.: Frequency of the DYT1 mutation in primary torsion dystonia without family history. Arch. Neurol. 57, 333-335 (2000).
114. Kamm C, Castelon-Konkiewitz E, Naumann M et al.: GAG deletion in the DYT1 gene in early limb-onset idiopathic torsion dystonia in Germany. Mov. Disord. 14, 681-683 (1999).
115. Im JH, Ahn TB, Kim KB, Ko SB, Jeon BS: DYT1 mutation in Korean primary dystonia patients. Parkinsonism Relat. Disord. 10, 421-423 (2004).
116. Asgeirsson H, Jakobsson F, Hjaltason H, Jonsdottir H, Sveinbjornsdottir S: Prevalence study of primary dystonia in Iceland. Mov. Disord. 21, 293-298 (2006)
117. Frédéric M, Lucarz E, Monino C et al.: First determination of the incidence of the unique TOR1A gene mutation, c.907delGAG, in a Mediterranean population. Mov. Disord. 22, 884-888 (2007).
118. Moretti P, Hedera P, Wald J, Fink J: Autosomal recessive primary generalized dystonia in two siblings from a consanguineous family. Mov. Disord. 20, 245-247 (2005).
119. Knappskog PM, Flatmark T, Mallet J, Ludecke B, Bartholome K: Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 1209-1212 (1995).
120. Ludecke B, Knappskog PM, Clayton PT et al.: Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 5, 1023-1028 (1996).
121. Ichinose H, Ohye T, Takahashi E et al.: Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 8, 236-242 (1994).
122. Tronnier VM, Fogel W: Pallidal stimulation for generalized dystonia. Report of three cases. J. Neurosurg. 92, 453-456 (2000).
123. Wilhelmsen K, Ketema M, Truong H, Sonnenberg A: KASH-domain proteins in nuclear migration, anchorage and other processes. J. Cell Sci. 119, 5021-5029 (2006).